van Ruiten CC, Veltman DJ, Wijdeveld M, Ten Kulve JS, et al. Combination therapy with exenatide decreases the dapagliflozin-induced changes in brain responses to anticipation and consumption of palatable food in patients with type 2 diabetes: a randomized controlled trial. Diabetes Obes Metab 2022 May 1. doi: 10.1111/dom.14732.
PMID: 35491524